Products are for professional/laboratory use only.
Invivoscribe LymphoTrack® products can be used for next-generation sequencing (NGS) determination and minimal residual disease (MRD) tracking of B- and T-cell gene rearrangements in subjects suspected of lymphoproliferations.
Products are for professional/laboratory use only
Within 180 minutes and with less than 2 minutes hands-on time, the fully automated Idylla™ GeneFusion cartridge detects ALK, ROS1 and RET fusions & MET exon 14 skipping in a single cartridge using only 1-3* FFPE tissue sections from patients with NSCLC.
Products are for professional/laboratory use only
Explore Recent Scientific Contributions Using Invivoscribe’s Products
Key opinion leaders across the world have recently published papers that discuss the advantages of using highly sensitive next-generation sequencing (NGS) for Minimal Residual Disease (MRD) testing.
Products are for professional/laboratory use only.
The Invivoscribe symposiums presented during the 25th European Hematology Association Virtual Congress are now available to watch on demand.
Products are for professional/laboratory use only.
This webinar will explore how insights gained through NGS translate to the development of improved treatment of lymphoid malignancies.
Products are for professional/laboratory use only.
Press Release: Mechelen, Belgium, 27 June 2018
Products are for professional/laboratory use only.
A new publication in the Journal of Clinical Pathology demonstrated that the Idylla EGFR Mutation Test (CE-IVD) was able to rescue 80% of the EGFR samples whose assessment was unsuccessful with Next Generation Sequencing (NGS).
